Literature DB >> 22011248

Association between pri-miR-218 polymorphism and risk of hepatocellular carcinoma in a Han Chinese population.

Lu-Shun Zhang1, Wei-Bo Liang, Lin-Bo Gao, Hong-Yu Li, Li-Juan Li, Peng-Yu Chen, Yun Liu, Tian-Yi Chen, Jun-Ge Han, Yong-Gang Wei, Lin Zhang.   

Abstract

MicroRNAs are noncoding RNA molecules of 18-25 nucleotides that regulate gene expression at the post-transcriptional level. The aim of this study was to investigate whether pri-miR-218 rs11134527 A/G polymorphism influences the risk of hepatocellular carcinoma (HCC) or not. pri-miR-218 rs11134527 A/G was genotyped in 302 HCC patients and 513 control subjects using the polymerase chain reaction-restriction fragment length polymorphism assay. The AG genotype of pri-miR-218 rs11134527 A/G was associated with family history (p=0.018, odds ratio [OR]=2.96, 95% confidence interval [CI]: 1.16-7.56) and elevated serum α-fetoprotein (serum alpha-fetoprotein [AFP]) levels (≥20 ng/mL; p=0.009, OR=1.92, 95% CI: 1.17-3.14) in HCC patients. These findings suggested that the AG genotype of pri-miR-218 rs11134527 might relate to genetic predisposition and be involved in regulating the expression of AFP in Chinese HCC patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22011248     DOI: 10.1089/dna.2011.1326

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  12 in total

1.  Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET.

Authors:  Chengjun Sui; Feng Xu; Weifeng Shen; Li Geng; Feng Xie; Binghua Dai; Jiongjiong Lu; Minfeng Zhang; Jiamei Yang
Journal:  Tumour Biol       Date:  2014-11-06

Review 2.  The associations and roles of microRNA single-nucleotide polymorphisms in cervical cancer.

Authors:  Yaheng Li; Chuanyin Li; Shuyuan Liu; Jia Yang; Li Shi; Yufeng Yao
Journal:  Int J Med Sci       Date:  2021-04-07       Impact factor: 3.738

Review 3.  New insights on the role of epigenetic alterations in hepatocellular carcinoma.

Authors:  Maddalena Frau; Claudio F Feo; Francesco Feo; Rosa M Pascale
Journal:  J Hepatocell Carcinoma       Date:  2014-06-12

Review 4.  Single nucleotide polymorphisms and cancer susceptibility.

Authors:  Na Deng; Heng Zhou; Hua Fan; Yuan Yuan
Journal:  Oncotarget       Date:  2017-11-07

5.  Association of Polymorphisms in three pri-miRNAs that Target Pepsinogen C with the Risk and Prognosis of Gastric Cancer.

Authors:  Ye-Feng Wu; Qian Xu; Cai-Yun He; Ying Li; Jing-Wei Liu; Na Deng; Li-Ping Sun; Yuan Yuan
Journal:  Sci Rep       Date:  2017-01-09       Impact factor: 4.379

6.  Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients.

Authors:  Min-Sun Kwak; Dong Hyeon Lee; Yuri Cho; Eun-Ju Cho; Jeong-Hoon Lee; Su Jong Yu; Jung-Hwan Yoon; Hyo-Suk Lee; Chung Yong Kim; Jae Youn Cheong; Sung Won Cho; Hyoung Doo Shin; Yoon Jun Kim
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

Review 7.  Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk.

Authors:  Kshitij Srivastava; Anvesha Srivastava
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

8.  Quantitative assessment of pre-miR-218 rs11134527 polymorphism and cancer risk in Chinese population.

Authors:  Hongyu Zhao; Rui Wang
Journal:  Onco Targets Ther       Date:  2015-07-24       Impact factor: 4.147

9.  The interaction effects of pri-let-7a-1 rs10739971 with PGC and ERCC6 gene polymorphisms in gastric cancer and atrophic gastritis.

Authors:  Qian Xu; Jing-wei Liu; Cai-yun He; Li-ping Sun; Yue-hua Gong; Jing-Jing Jing; Cheng-zhong Xing; Yuan Yuan
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

10.  Association between a variant in microRNA-646 and the susceptibility to hepatocellular carcinoma in a large-scale population.

Authors:  Rui Wang; Jun Zhang; Weiru Jiang; Yanyun Ma; Wenshuai Li; Bohan Jin; Heping Hu; Jiucun Wang; Yi Liu; Jie Liu
Journal:  ScientificWorldJournal       Date:  2014-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.